Publisher: Adis International
ISSN: 1173-8324
Source: Inpharma, Vol.1, Iss.1587, 2007-01, pp. : 11-11
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Zoledronic acid reduces recurrence risk in women with EBC
Inpharma, Vol. 1, Iss. 1641, 2008-01 ,pp. :
Zoledronic acid reduces skeletal complications in prostate cancer
Inpharma, Vol. 1, Iss. 1364, 2002-01 ,pp. :
Estrogen/medroxyprogesterone reduces fracture risk
Inpharma, Vol. 1, Iss. 1408, 2003-01 ,pp. :
Pamidronic acid/zoledronic acid: Subtrochanteric femoral fracture: 4 case reports
Reactions Weekly, Vol. 1, Iss. 1380, 2011-01 ,pp. :
Risk of fracture with alendronic acid
Inpharma, Vol. 1, Iss. 1587, 2007-01 ,pp. :